Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vito Barbieri

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Cell Death and Differentiation|July 7, 2018
BMP9 counteracts the tumorigenic and pro-angiogenic potential of glioblastomaElena Porcù, Francesca Maule, Daniele Boso, et al.
Oncoscience|January 17, 2015
Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patientsElisabetta Rossi, Massimo Rugge, Antonella Facchinetti, et al.
Carcinogenesis|February 25, 2009
Interferon-alpha counteracts the angiogenic switch and reduces tumor cell proliferation in a spontaneous model of prostatic cancerLuca Persano, Lidia Moserle, Giovanni Esposito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2014
Functional avidity-driven activation-induced cell death shapes CTL immunodominanceSilvia Dalla Santa, Anna Merlo, Sara Bobisse, et al.
BMJ Supportive & Palliative Care|February 12, 2026
Travel burden and telemedicine in home-based palliative care: potential and limitations - prospective analysisMaria Anna Siciliano, Giulio Ravoni, Miriam Bertulini, et al.
Therapeutic Advances in Chronic Disease|January 24, 2022
Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case reportMaria d'Apolito, Rocco Spagnuolo, Maria Anna Siciliano, et al.
Biomedicines|May 28, 2022
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and PharmacogenomicsNicoletta Staropoli, Mariamena Arbitrio, Angela Salvino, et al.
Cancer Chemotherapy and Pharmacology|November 27, 2015
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysisMariamena Arbitrio, Maria Teresa Di Martino, Vito Barbieri, et al.
Cellular & Molecular Immunology|March 25, 2021
Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccinesAnna Dalla Pietà, Debora Carpanese, Antonella Grigoletto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 6, 2026
Cytisine for Smoking Cessation Within a Lung Cancer Screening Program: Results From the Italian RISP TrialMassimiliano Cani, Daniela Bafunno, Francesca Caumo, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Cell Death and Differentiation|July 7, 2018
BMP9 counteracts the tumorigenic and pro-angiogenic potential of glioblastomaElena Porcù, Francesca Maule, Daniele Boso, et al.
Oncoscience|January 17, 2015
Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patientsElisabetta Rossi, Massimo Rugge, Antonella Facchinetti, et al.
Carcinogenesis|February 25, 2009
Interferon-alpha counteracts the angiogenic switch and reduces tumor cell proliferation in a spontaneous model of prostatic cancerLuca Persano, Lidia Moserle, Giovanni Esposito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2014
Functional avidity-driven activation-induced cell death shapes CTL immunodominanceSilvia Dalla Santa, Anna Merlo, Sara Bobisse, et al.
BMJ Supportive & Palliative Care|February 12, 2026
Travel burden and telemedicine in home-based palliative care: potential and limitations - prospective analysisMaria Anna Siciliano, Giulio Ravoni, Miriam Bertulini, et al.
Therapeutic Advances in Chronic Disease|January 24, 2022
Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case reportMaria d'Apolito, Rocco Spagnuolo, Maria Anna Siciliano, et al.
Biomedicines|May 28, 2022
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and PharmacogenomicsNicoletta Staropoli, Mariamena Arbitrio, Angela Salvino, et al.
Cancer Chemotherapy and Pharmacology|November 27, 2015
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysisMariamena Arbitrio, Maria Teresa Di Martino, Vito Barbieri, et al.
Cellular & Molecular Immunology|March 25, 2021
Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccinesAnna Dalla Pietà, Debora Carpanese, Antonella Grigoletto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 6, 2026
Cytisine for Smoking Cessation Within a Lung Cancer Screening Program: Results From the Italian RISP TrialMassimiliano Cani, Daniela Bafunno, Francesca Caumo, et al.
Pageof 5